Moxifloxacin Single-Dose Vial (Denver Solutions) – glass delamination (2024)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-097-42
Brand
Denver Solutions, LLC DBA Leiters Health
Lot Codes / Batch Numbers
Lot #:2331123, Exp:28-Feb-24, 2331298, Exp: 24-Mar-24.
Products Sold
Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24.
Denver Solutions, LLC DBA Leiters Health is recalling Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO due to Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026